CASI Pharmaceuticals, Inc. To Present At H.C. Wainwright Bioconnect Conference

On January 8, 2021 CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, reported that Dr. Wei-Wu He, Chairman and Chief Executive Officer of CASI Pharmaceuticals, will be presenting at the H.C.Wainwright Bioconnect Conference. Details for the virtual conferences are as follows (Press release, CASI Pharmaceuticals, JAN 8, 2021, https://www.prnewswire.com/news-releases/casi-pharmaceuticals-inc-to-present-at-hc-wainwright-bioconnect-conference-301203238.html [SID1234573726]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C.Wainwright Bioconnect Conference
Date: Monday, January 11th
Time: 6:00 AM (ET)

Webcast or external link of the company presentations will be available under "Events & Presentations" in the "Investors Relations" section of CASI’s website. Archived replays will be available for approximately 90 days following the event.